Research makes our communities stronger.
We help by providing extensively tested peptides that have been certified by FDA-registered labs to optimize your research endeavors.
Peptide Systems was founded with a mission to serve as a trusted guide, helping you make informed decisions that will shape the future of your research.
Time and again, published scientific, peer-reviewed reports indicate that peptides are a promising area of research with the potential to benefit numerous clinical indications.
Supporting Our Heroes
We proudly donate 5% of our proceeds to Veterans Exploring Treatment Solutions, helping our veterans find the healing they deserve.
Since 2019, the non-profit Veterans Exploring Treatment Solutions has been helping veterans find outside the box treatment solutions.
You can visit their website to learn more at:
VetSolutions.org
Founded by a scientist,
providing peptides you can trust.
Johnathon Anderson, PhD
Founder
Frustrated by the lack of high quality peptides available on the market,
we decided it was time for a change.
We extensively test each product in FDA-registered labs that have
ISO 17025:2017 certification.
So people have a source for peptides that they can trust.
Dr. Anderson is a research scientist and Associate Professor at the UC Davis School of Medicine and Institute for Regenerative Cures. His research as a drug discovery and development researcher revolves around regenerative medicine, including stem cell and gene therapies. His work has spanned the translational pipeline from early stage proof of concept studies to managing multiple clinical trials. He's also a jiu jitsu blue belt.
Dr. Johnathon Anderson received his BS and PhD degrees from the University of California Davis. We has been awarded numerous prestigious fellowships for his work including: NSF GRFP, NIH T32, and NIH KL2 fellowships. He has authored over 20 scientific peer-reviewed publications that have been cited over 11,000 times, and been a co-inventor on two patent applications for regenerative medicine therapies for stem cell and exosome-based therapies. He has also trained at the National Institutes of Health, the Karolinska Institute in Stockholm, and Oxford University in the United Kingdom.